Fennessy M, Metcalfe K, Hitman G A, Niven M, Biro P A, Tuomilehto J, Tuomilehto-Wolf E
Department of Medicine, Royal London Hospital, UK.
Diabetologia. 1994 Sep;37(9):937-44. doi: 10.1007/BF00400951.
In Finland the haplotype A2, Cw1, B56, DR4, DQ8 is the third most common haplotype in insulin-dependent diabetic (IDDM) patients and has the highest haplotype-specific absolute risk for IDDM. Cw1, B56, DR4, DQ8 haplotypes containing HLA-A alleles other than A2 are infrequent in the population and are not associated with IDDM. Comparison of the A2 and non-A2 haplotypes at the DNA level showed that they were identical at HLA-B, -DR, and -DQ loci. Evidence that class I alleles confer susceptibility to IDDM was obtained from the two HLA-C, -B, -DR and -DQ haplotypes most frequently found in IDDM patients in Finland. A24, A3 and A2 on the Cw3, B62, DR4, DQ8 haplotype, and A28, A2 and A1 on the Cw7, B8, DR3, DQ2 were all found to be associated with IDDM. In Finland these seven haplotypes, including A2, Cw1, B56, DR4, DQ8, account for 33% of diabetic haplotypes and 10.3% of non-diabetic haplotypes (p < 0.00001). The contribution of the class I region to IDDM susceptibility was also apparent in those IDDM patients lacking the disease-predisposing class II alleles. Significantly more non-DR3/non-DR4 IDDM patients (47 of 55) possessed two of the IDDM-associated HLA-A alleles compared to non-DR3/non-DR4 control subjects (40 of 58; p = 0.038). Moreover, IDDM patients confirmed by oligotyping as unable to form a 'diabetes-susceptibility' DQ heterodimer, tended to possess two diabetes-associated HLA-A alleles (12 of 13) compared to control subjects (12 of 20; p = 0.056).
在芬兰,单倍型A2、Cw1、B56、DR4、DQ8是胰岛素依赖型糖尿病(IDDM)患者中第三常见的单倍型,且具有IDDM最高的单倍型特异性绝对风险。包含除A2之外的HLA - A等位基因的Cw1、B56、DR4、DQ8单倍型在人群中很少见,且与IDDM无关。在DNA水平上对A2和非A2单倍型进行比较,结果显示它们在HLA - B、- DR和 - DQ基因座上是相同的。关于I类等位基因赋予IDDM易感性的证据来自于在芬兰IDDM患者中最常发现的两种HLA - C、- B、- DR和 - DQ单倍型。在Cw3、B62、DR4、DQ8单倍型上的A24、A3和A2,以及在Cw7、B8、DR3、DQ2单倍型上的A28、A2和A1均被发现与IDDM相关。在芬兰,这七种单倍型,包括A2、Cw1、B56、DR4、DQ8,占糖尿病单倍型的33%,非糖尿病单倍型的10.3%(p < 0.00001)。I类区域对IDDM易感性的贡献在那些缺乏疾病易感II类等位基因的IDDM患者中也很明显。与非DR3/非DR4对照受试者(58人中的40人;p = 0.038)相比,显著更多的非DR3/非DR4 IDDM患者(55人中的47人)拥有两个与IDDM相关的HLA - A等位基因。此外,通过寡核苷酸分型确认无法形成“糖尿病易感”DQ异二聚体的IDDM患者,与对照受试者(20人中的12人;p = 0.056)相比,倾向于拥有两个与糖尿病相关的HLA - A等位基因(13人中的12人)。